Article Details
Retrieved on: 2018-01-04 20:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>CAMBRIDGE, Mass.--(Business Wire)--Magenta Therapeutics, a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, today announced that Jason Gardner, D.Phil., CEO, president and co-founder of Magenta, will provide a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here